AR: Sterigenics Completes $16.8M Expansion to West Memphis Facility
15 Jun, 2017
Sterigenics International LLC, the leading global provider of contract sterilization, lab services, gamma technologies and medical isotopes, and a portfolio company of Warburg Pincus and GTCR, has completed a $16.8 million expansion to its West Memphis, Arkansas, facility, nearly tripling the facility's gamma sterilization capacity.
Originally opened in 1999, the current expansion adds a state-of-the art Nordion JS10000 irradiator and boosts the total licensed throughput at West Memphis nearly three-fold, enough capacity to process approximately 50,000 additional pallets of product annually.
"Sterigenics International is committed to being the world's leading provider of sterilization services," said Philip Macnabb, President of Sterigenics. "We are seeing significant demand for more Gamma capacity in the Southwest, which is why we decided to make this investment in West Memphis. This expansion is a first in a series of investments in capacity that we will be making. It is a very exciting time for our company."
"Memphis is a key regional logistics hub with a growing demand for sterilization services," said Susan Hope, General Manager of the West Memphis facility. "Our customers have been anxiously waiting for this expansion to come on line and we are looking forward to working with them to take advantage of the faster turnaround we now offer."
At full capacity, the expanded West Memphis facility will add approximately 20 new employees and will allow Sterigenics to better serve customers throughout the region.
About Sterigenics International LLC
Sterigenics International LLC, along with its affiliates, is a global leader in outsourced contract sterilization services, laboratory services, gamma technologies and medical isotopes, and the only vertically integrated sterilization company in the world. Operating out of 43 facilities in 13 countries across the Americas, Europe and Asia, Sterigenics provides contract sterilization and ionization services for the medical device, pharmaceutical, food safety, and high-performance materials industries. Its affiliate Nordion positions Sterigenics as the world's largest provider of Cobalt-60 used in the gamma sterilization process as well as medical isotopes used in the diagnosis and treatment of various diseases and cancers. Through Nelson Labs, Sterigenics offers microbiological and analytical testing and consultancy to assist customers in developing and maintaining sterilization solutions in medical devices, tissue/implantable products, and pharmaceuticals and biologics fields. Sterigenics International LLC and its affiliates serve more than 2,500 customers around the world and is owned by private equity firms Warburg Pincus and GTCR. Learn more about Sterigenics at sterigenics.com, about Nordion at nordion.com and about Nelson Labs at nelsonlabs.com.